Nathan Patterson, MD
Plastic and Reconstructive Surgery · Pensacola, FLNPI 1952341190
Payments from drug & device makers
Across 76 payments — averaging $53.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Motiva USA, LLC$579
- Merz North America, Inc.$509
- Musculoskeletal Transplant Foundation Inc.$424
- Sientra, Inc.$321
- Mentor Worldwide LLC$157
- plus $336 from 6 others
Across 1 payment — averaging $250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sientra, Inc.$250
What the payments were for
- Speaking & faculty fees$73318%
- Travel & lodging$66616%
- Food & beverage$2,63765%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $1,709 |
| Motiva USA, LLC | 6 | $579 |
| Merz North America, Inc. | 5 | $509 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $424 |
| Sientra, Inc. | 6 | $321 |
| Mentor Worldwide LLC | 6 | $157 |
| Galderma Laboratories, L.p. | 1 | $142 |
| TELA Bio, Inc. | 4 | $76 |
| Stryker | 2 | $69 |
| Integra Lifesciences Corporation | 1 | $22 |
| Revance Therapeutics, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,036 in reported general payments places this provider in the 50th percentile of 235 plastic and reconstructive surgery providers in Florida.
See all plastic and reconstructive surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 22 | $286 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $216 |
| Celecoxib | 18 | $202 |
| Scopolamine | 13 | $133 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Pensacola
- Jocelyn LevequePensacola$21K
- Luis AponteTampa$840K
- Alan DurkinVero Beach$549K
- Edgar SosaVero Beach$504K
- Sai Ramakrishna Velamuri VenkataTampa$317K
- Vaishali DoolabhJacksonville$313K
- David SmithTampa$226K
- Lee GibsteinBay Harbor Islands$216K
- John MurrayJacksonville$188K
- Arthur DesrosiersMiami$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.